CorMedix (CRMD) Accounts Payables (2010 - 2025)

CorMedix has disclosed Accounts Payables across 15 years of filings, most recently posting $7.9 million for Q4 2025.

• Accounts Payables for Q4 2025 came in at $7.9 million, up 358.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.9 million (up 358.37% YoY), and the FY2025 annual result was $7.9 million, up 358.37% from the prior year.
• Accounts Payables came in at $7.9 million for Q4 2025 at CorMedix, down from $20.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $20.5 million in Q3 2025 to a low of $943344.0 in Q2 2021.
• The 5-year median for Accounts Payables is $2.2 million (2021), against an average of $3.5 million.
• Across the five-year window, Accounts Payables plunged 60.69% in 2021 and jumped 1422.09% in 2025, its largest moves.
• CorMedix's Accounts Payables stood at $2.2 million in 2021, then declined by 0.34% to $2.2 million in 2022, then surged by 94.34% to $4.3 million in 2023, then tumbled by 59.81% to $1.7 million in 2024, then surged by 358.37% to $7.9 million in 2025.
• The last three Accounts Payables figures came in at $7.9 million (Q4 2025), $20.5 million (Q3 2025), and $5.8 million (Q2 2025), per Business Quant data.